China Osteoarthritis Pain Medicine Market Report & Forecast 2021-2027

China Osteoarthritis Pain Medicine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Osteoarthritis Pain Medicine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Osteoarthritis Pain Medicine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Osteoarthritis Pain Medicine Overall Market Size
2.1 China Osteoarthritis Pain Medicine Market Size: 2021 VS 2027
2.2 China Osteoarthritis Pain Medicine Revenue, Prospects & Forecasts: 2016-2027
2.3 China Osteoarthritis Pain Medicine Sales: 2016-2027
3 Company Landscape
3.1 Top Osteoarthritis Pain Medicine Players in China Market
3.2 Top China Osteoarthritis Pain Medicine Companies Ranked by Revenue
3.3 China Osteoarthritis Pain Medicine Revenue by Companies
3.4 China Osteoarthritis Pain Medicine Sales by Companies
3.5 China Osteoarthritis Pain Medicine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Osteoarthritis Pain Medicine Companies in China Market, by Revenue in 2020
3.7 Manufacturers Osteoarthritis Pain Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Osteoarthritis Pain Medicine Players in China Market
3.8.1 List of Tier 1 Osteoarthritis Pain Medicine Companies in China
3.8.2 List of Tier 2 and Tier 3 Osteoarthritis Pain Medicine Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Osteoarthritis Pain Medicine Market Size Markets, 2021 & 2027
4.1.2 Oral
4.1.3 Injection
4.1.4 External
4.2 By Type - China Osteoarthritis Pain Medicine Revenue & Forecasts
4.2.1 By Type - China Osteoarthritis Pain Medicine Revenue, 2016-2021
4.2.2 By Type - China Osteoarthritis Pain Medicine Revenue, 2022-2027
4.2.3 By Type - China Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
4.3 By Type - China Osteoarthritis Pain Medicine Sales & Forecasts
4.3.1 By Type - China Osteoarthritis Pain Medicine Sales, 2016-2021
4.3.2 By Type - China Osteoarthritis Pain Medicine Sales, 2022-2027
4.3.3 By Type - China Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
4.4 By Type - China Osteoarthritis Pain Medicine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Osteoarthritis Pain Medicine Market Size, 2021 & 2027
5.1.2 Medical Care
5.1.3 Personal Care
5.2 By Application - China Osteoarthritis Pain Medicine Revenue & Forecasts
5.2.1 By Application - China Osteoarthritis Pain Medicine Revenue, 2016-2021
5.2.2 By Application - China Osteoarthritis Pain Medicine Revenue, 2022-2027
5.2.3 By Application - China Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
5.3 By Application - China Osteoarthritis Pain Medicine Sales & Forecasts
5.3.1 By Application - China Osteoarthritis Pain Medicine Sales, 2016-2021
5.3.2 By Application - China Osteoarthritis Pain Medicine Sales, 2022-2027
5.3.3 By Application - China Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
5.4 By Application - China Osteoarthritis Pain Medicine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Overview
6.1.3 Pfizer Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.1.4 Pfizer Osteoarthritis Pain Medicine Product Description
6.1.5 Pfizer Recent Developments
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Overview
6.2.3 Johnson and Johnson Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.2.4 Johnson and Johnson Osteoarthritis Pain Medicine Product Description
6.2.5 Johnson and Johnson Recent Developments
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Overview
6.3.3 GlaxoSmithKline Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.3.4 GlaxoSmithKline Osteoarthritis Pain Medicine Product Description
6.3.5 GlaxoSmithKline Recent Developments
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Overview
6.4.3 Bayer Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.4.4 Bayer Osteoarthritis Pain Medicine Product Description
6.4.5 Bayer Recent Developments
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Overview
6.5.3 Eli Lilly Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.5.4 Eli Lilly Osteoarthritis Pain Medicine Product Description
6.5.5 Eli Lilly Recent Developments
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Overview
6.6.3 Novartis Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.6.4 Novartis Osteoarthritis Pain Medicine Product Description
6.6.5 Novartis Recent Developments
6.7 Sanofi
6.7.1 Sanofi Corporation Information
6.7.2 Sanofi Overview
6.7.3 Sanofi Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.7.4 Sanofi Osteoarthritis Pain Medicine Product Description
6.7.5 Sanofi Recent Developments
6.8 Horizon Pharma
6.8.1 Horizon Pharma Corporation Information
6.8.2 Horizon Pharma Overview
6.8.3 Horizon Pharma Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.8.4 Horizon Pharma Osteoarthritis Pain Medicine Product Description
6.8.5 Horizon Pharma Recent Developments
6.9 Abbott
6.9.1 Abbott Corporation Information
6.9.2 Abbott Overview
6.9.3 Abbott Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.9.4 Abbott Osteoarthritis Pain Medicine Product Description
6.9.5 Abbott Recent Developments
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Overview
6.10.3 Mylan Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.10.4 Mylan Osteoarthritis Pain Medicine Product Description
6.10.5 Mylan Recent Developments
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Corporation Information
6.11.2 Daiichi Sankyo Overview
6.11.3 Daiichi Sankyo Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.11.4 Daiichi Sankyo Osteoarthritis Pain Medicine Product Description
6.11.5 Daiichi Sankyo Recent Developments
6.12 TEVA
6.12.1 TEVA Corporation Information
6.12.2 TEVA Overview
6.12.3 TEVA Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.12.4 TEVA Osteoarthritis Pain Medicine Product Description
6.12.5 TEVA Recent Developments
6.13 Almatica Pharma
6.13.1 Almatica Pharma Corporation Information
6.13.2 Almatica Pharma Overview
6.13.3 Almatica Pharma Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.13.4 Almatica Pharma Osteoarthritis Pain Medicine Product Description
6.13.5 Almatica Pharma Recent Developments
6.14 Astellas Pharma
6.14.1 Astellas Pharma Corporation Information
6.14.2 Astellas Pharma Overview
6.14.3 Astellas Pharma Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.14.4 Astellas Pharma Osteoarthritis Pain Medicine Product Description
6.14.5 Astellas Pharma Recent Developments
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Corporation Information
6.15.2 Tide Pharmaceutical Overview
6.15.3 Tide Pharmaceutical Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.15.4 Tide Pharmaceutical Osteoarthritis Pain Medicine Product Description
6.15.5 Tide Pharmaceutical Recent Developments
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Corporation Information
6.16.2 Iroko Pharmaceuticals Overview
6.16.3 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.16.4 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product Description
6.16.5 Iroko Pharmaceuticals Recent Developments
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Corporation Information
6.17.2 Hengrui Pharmaceutical Overview
6.17.3 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.17.4 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product Description
6.17.5 Hengrui Pharmaceutical Recent Developments
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Corporation Information
6.18.2 Abiogen Pharma Overview
6.18.3 Abiogen Pharma Osteoarthritis Pain Medicine Sales and Revenue in China Market (2016-2021)
6.18.4 Abiogen Pharma Osteoarthritis Pain Medicine Product Description
6.18.5 Abiogen Pharma Recent Developments
7 China Osteoarthritis Pain Medicine Production Capacity, Analysis
7.1 China Osteoarthritis Pain Medicine Production Capacity, 2016-2027
7.2 Osteoarthritis Pain Medicine Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Osteoarthritis Pain Medicine Supply Chain Analysis
9.1 Osteoarthritis Pain Medicine Industry Value Chain
9.2 Osteoarthritis Pain Medicine Upstream Market
9.3 Osteoarthritis Pain Medicine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Osteoarthritis Pain Medicine Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Osteoarthritis Pain Medicine in China Market
Table 2. Top Osteoarthritis Pain Medicine Players in China Market, Ranking by Revenue (2019)
Table 3. China Osteoarthritis Pain Medicine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Osteoarthritis Pain Medicine Revenue Share by Companies, 2016-2021
Table 5. China Osteoarthritis Pain Medicine Sales by Companies, (K Units), 2016-2021
Table 6. China Osteoarthritis Pain Medicine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Osteoarthritis Pain Medicine Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Osteoarthritis Pain Medicine Product Type
Table 9. List of Tier 1 Osteoarthritis Pain Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Osteoarthritis Pain Medicine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Oral
Table 12. Major Manufacturers of Injection
Table 13. By Type - China Osteoarthritis Pain Medicine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Osteoarthritis Pain Medicine Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Osteoarthritis Pain Medicine Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Osteoarthritis Pain Medicine Sales (K Units), 2016-2021
Table 17. By Type - China Osteoarthritis Pain Medicine Sales (K Units), 2022-2027
Table 18. By Application - China Osteoarthritis Pain Medicine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Osteoarthritis Pain Medicine Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Osteoarthritis Pain Medicine Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Osteoarthritis Pain Medicine Sales (K Units), 2016-2021
Table 22. By Application - China Osteoarthritis Pain Medicine Sales (K Units), 2022-2027
Table 23. Pfizer Corporation Information
Table 24. Pfizer Description and Major Businesses
Table 25. Pfizer Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Pfizer Osteoarthritis Pain Medicine Product
Table 27. Pfizer Recent Developments
Table 28. Johnson and Johnson Corporation Information
Table 29. Johnson and Johnson Description and Major Businesses
Table 30. Johnson and Johnson Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Johnson and Johnson Osteoarthritis Pain Medicine Product
Table 32. Johnson and Johnson Recent Developments
Table 33. GlaxoSmithKline Corporation Information
Table 34. GlaxoSmithKline Description and Major Businesses
Table 35. GlaxoSmithKline Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. GlaxoSmithKline Osteoarthritis Pain Medicine Product
Table 37. GlaxoSmithKline Recent Developments
Table 38. Bayer Corporation Information
Table 39. Bayer Description and Major Businesses
Table 40. Bayer Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Bayer Osteoarthritis Pain Medicine Product
Table 42. Bayer Recent Developments
Table 43. Eli Lilly Corporation Information
Table 44. Eli Lilly Description and Major Businesses
Table 45. Eli Lilly Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Eli Lilly Osteoarthritis Pain Medicine Product
Table 47. Eli Lilly Recent Developments
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Major Businesses
Table 50. Novartis Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. Novartis Osteoarthritis Pain Medicine Product
Table 52. Novartis Recent Developments
Table 53. Sanofi Corporation Information
Table 54. Sanofi Description and Major Businesses
Table 55. Sanofi Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. Sanofi Osteoarthritis Pain Medicine Product
Table 57. Sanofi Recent Developments
Table 58. Horizon Pharma Corporation Information
Table 59. Horizon Pharma Description and Major Businesses
Table 60. Horizon Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Horizon Pharma Osteoarthritis Pain Medicine Product
Table 62. Horizon Pharma Recent Developments
Table 63. Abbott Corporation Information
Table 64. Abbott Description and Major Businesses
Table 65. Abbott Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Abbott Osteoarthritis Pain Medicine Product
Table 67. Abbott Recent Developments
Table 68. Mylan Corporation Information
Table 69. Mylan Description and Major Businesses
Table 70. Mylan Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Mylan Osteoarthritis Pain Medicine Product
Table 72. Mylan Recent Developments
Table 73. Daiichi Sankyo Corporation Information
Table 74. Daiichi Sankyo Description and Major Businesses
Table 75. Daiichi Sankyo Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Daiichi Sankyo Osteoarthritis Pain Medicine Product
Table 77. Daiichi Sankyo Recent Developments
Table 78. TEVA Corporation Information
Table 79. TEVA Description and Major Businesses
Table 80. TEVA Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. TEVA Osteoarthritis Pain Medicine Product
Table 82. TEVA Recent Developments
Table 83. Almatica Pharma Corporation Information
Table 84. Almatica Pharma Description and Major Businesses
Table 85. Almatica Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 86. Almatica Pharma Osteoarthritis Pain Medicine Product
Table 87. Almatica Pharma Recent Developments
Table 88. Astellas Pharma Corporation Information
Table 89. Astellas Pharma Description and Major Businesses
Table 90. Astellas Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 91. Astellas Pharma Osteoarthritis Pain Medicine Product
Table 92. Astellas Pharma Recent Developments
Table 93. Tide Pharmaceutical Corporation Information
Table 94. Tide Pharmaceutical Description and Major Businesses
Table 95. Tide Pharmaceutical Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 96. Tide Pharmaceutical Osteoarthritis Pain Medicine Product
Table 97. Tide Pharmaceutical Recent Developments
Table 98. Iroko Pharmaceuticals Corporation Information
Table 99. Iroko Pharmaceuticals Description and Major Businesses
Table 100. Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 101. Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product
Table 102. Iroko Pharmaceuticals Recent Developments
Table 103. Hengrui Pharmaceutical Corporation Information
Table 104. Hengrui Pharmaceutical Description and Major Businesses
Table 105. Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 106. Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product
Table 107. Hengrui Pharmaceutical Recent Developments
Table 108. Abiogen Pharma Corporation Information
Table 109. Abiogen Pharma Description and Major Businesses
Table 110. Abiogen Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 111. Abiogen Pharma Osteoarthritis Pain Medicine Product
Table 112. Abiogen Pharma Recent Developments
Table 113. Osteoarthritis Pain Medicine Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)
Table 114. China Osteoarthritis Pain Medicine Capacity Market Share of Key Manufacturers, 2019-2021
Table 115. Osteoarthritis Pain Medicine Market Opportunities & Trends in China Market
Table 116. Osteoarthritis Pain Medicine Market Drivers in China Market
Table 117. Osteoarthritis Pain Medicine Market Restraints in China Market
Table 118. Osteoarthritis Pain Medicine Raw Materials
Table 119. Osteoarthritis Pain Medicine Raw Materials Suppliers in China Market
Table 120. Typical Osteoarthritis Pain Medicine Downstream
Table 121. Osteoarthritis Pain Medicine Downstream Clients in China Market
Table 122. Osteoarthritis Pain Medicine Distributors and Sales Agents in China Market
List of Figures
Figure 1. Osteoarthritis Pain Medicine Product Picture
Figure 2. Osteoarthritis Pain Medicine Segment by Type
Figure 3. Osteoarthritis Pain Medicine Segment by Application
Figure 4. China Osteoarthritis Pain Medicine Market Overview: 2020
Figure 5. China Osteoarthritis Pain Medicine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Osteoarthritis Pain Medicine Revenue, 2016-2027 (US$, Mn)
Figure 7. Osteoarthritis Pain Medicine Sales in China Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Osteoarthritis Pain Medicine Revenue in 2020
Figure 9. Oral Product Picture
Figure 10. Injection Product Picture
Figure 11. External Product Picture
Figure 12. By Type - China Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
Figure 13. By Type - China Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
Figure 14. By Type - China Osteoarthritis Pain Medicine Price (USD/Unit), 2016-2027
Figure 15. Medical Care
Figure 16. Personal Care
Figure 17. By Application - China Osteoarthritis Pain Medicine Sales Market Share, 2016-2027
Figure 18. By Application - China Osteoarthritis Pain Medicine Revenue Market Share, 2016-2027
Figure 19. By Application - China Osteoarthritis Pain Medicine Price (USD/Unit), 2016-2027
Figure 20. Pfizer Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Johnson and Johnson Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. GlaxoSmithKline Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bayer Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Eli Lilly Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Novartis Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Sanofi Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Horizon Pharma Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Abbott Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Mylan Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Daiichi Sankyo Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. TEVA Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Almatica Pharma Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Astellas Pharma Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Tide Pharmaceutical Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Iroko Pharmaceuticals Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Hengrui Pharmaceutical Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Abiogen Pharma Osteoarthritis Pain Medicine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. China Osteoarthritis Pain Medicine Production Capacity (K Units), 2016-2027
Figure 39. Osteoarthritis Pain Medicine Industry Value Chain
Figure 40. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs